The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Eric Groce
- Vol. 104, Iss: 4, pp 32-32
Reads0
Chats0
TLDR
Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the shortand long-term health effects—both harms and benefits—of cannabis use remains elusive.Abstract:
Recent years have seen a rapid rise in the medical and recreational use of cannabis: a broad term that can be used to describe the various products and chemical compounds (e.g., marijuana, cannabinoids) derived from different species of the cannabis plant. Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the shortand long-term health effects—both harms and benefits—of cannabis use remains elusive.read more
Citations
More filters
Journal ArticleDOI
[Interim analysis of the survey accompanying insurance-covered prescriptions of cannabis-based medicines in Germany].
TL;DR: The results of the accompanying survey are the basis on which the Joint Federal Committee (G-BA) regulates the future assumption of treatment costs in the context of a therapy with cannabis medicines in accordance with the Social Code (SGB) V.
Journal ArticleDOI
Narrative subscription in public policy discourse
TL;DR: Affect and identity are often recognized as important considerations in critical policy studies, but because these notions lack materiality, it is not observably obvious how they function in policy as discussed by the authors.
Journal ArticleDOI
Cannabidiol (CBD): Perspectives from Pinterest.
TL;DR: Social media has become a powerful source of health information and widespread acceptance of the use of CBD products with minimal information from reliable public health sources represented is revealed.
Journal ArticleDOI
Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence.
Shanna Babalonis,Sharon L. Walsh +1 more
TL;DR: There is a groundswell of public advocacy supporting the use of cannabis and cannabinoids to replace opioid analgesics or to reduce opioid use; however, the extant controlled clinical data do not support the role of cannabinoids for opioid replacement or opioid-sparing effects when treating opioid use disorder or chronic pain.
Journal ArticleDOI
Understanding Cancer Survivors’ Reasons to Medicate With Cannabis: A Qualitative Study Based on the Theory of Planned Behavior
Helen McTaggart-Cowan,Colene Bentley,Adam J. N. Raymakers,Rebecca Metcalfe,Philippa Hawley,Stuart Peacock +5 more
TL;DR: Prior to nonmedical cannabis legalization in Canada, individuals were only able to access cannabis legally through licensed producers with medical authorization, but with an additional legal access system designed for nonmedical purposes, it is unclear what factors influence cancer survivors’ decisions to medicate or not medicate cannabis.
References
More filters
Journal ArticleDOI
Diagnostic and Statistical Manual of Mental Disorders
Vijay A. Mittal,Elaine F. Walker +1 more
TL;DR: An issue concerning the criteria for tic disorders is highlighted, and how this might affect classification of dyskinesias in psychotic spectrum disorders.
Journal ArticleDOI
Systematic Review: Process of Forming Academic Service Partnerships to Reform Clinical Education
TL;DR: This study’s findings can provide practical guidelines to steer partnership programs within the academic and clinical bodies, with the aim of providing a collaborative partnership approach to clinical education.
Journal ArticleDOI
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
Julian P T Higgins,Douglas G. Altman,Peter C Gøtzsche,Peter Jüni,David Moher,Andrew D Oxman,Jelena Savović,Kenneth F. Schulz,Laura Weeks,Jonathan A C Sterne +9 more
TL;DR: The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
TL;DR: The Newcastle-Ottawa Scale (NOS) as discussed by the authors was developed to assess the quality of nonrandomised studies with its design, content and ease of use directed to the task of incorporating the quality assessments in the interpretation of meta-analytic results.
Journal ArticleDOI
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa Hm Moore,Stanley Zammit,Stanley Zammit,Anne Lingford-Hughes,Thomas R. E. Barnes,Peter B. Jones,Margaret Burke,Glyn Lewis +7 more
TL;DR: There is now sufficient evidence to warn young people that using cannabis could increase their risk of developing a psychotic illness later in life, although evidence for affective outcomes is less strong.